- Author:
Yongwhi PARK
1
;
Ae-Young HER
;
Hyun Kuk KIM
;
Jae Youn MOON
;
Jae Hyoung PARK
;
Keun-Ho PARK
;
Kyung Hoon LEE
;
Hyung Joon JOO
;
Ho Yeon WON
;
Sung Gyun AHN
;
Hong Jun PARK
;
Sung-Jin HONG
;
Beom Joon KIM
;
Seung Pil BAN
;
Jung-Won SUH
;
Young Bin SONG
;
Jung Rae CHO
;
Young-Hoon JEONG
;
Weon KIM
;
Eun-Seok SHIN
;
Author Information
- Publication Type:15
- From:Korean Journal of Medicine 2022;97(4):204-228
- CountryRepublic of Korea
- Language:Korean
- Abstract: Given the progressive improvements in antithrombotic strategies, management of cardiovascular disease has become sophisticated/refined. However, the optimal perioperative management of antithrombotic therapy in patients with acute coronary syndrome or who are scheduled for percutaneous coronary intervention remains unclear. Assessments of the thrombotic and hemorrhagic risks are essential to reduce the rates of mortality and major cardiac events. However, the existing guidelines do not mention these topics. This case-based consensus document deals with common clinical scenarios and offers evidence-based guidelines for individualized perioperative management of antithrombotic therapy in the real world.